Lexicon Pharmaceuticals, Inc. (LXRX) — Dilution Risk Analysis

Current Snapshot

Lexicon Pharmaceuticals, Inc. (LXRX) has a DilutionWatch score of 35/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
444,955,934 Source
Public Float
394,680,666 Source
Float as % of Outstanding
88.7%

Dilution Risk Score

Score: 35/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 8-K 1, 4 8.

FormFiledAccession
xbrl 2026-06-30 xbrl-3829-xbrl_warrant
8-K 2026-04-30 0001062822-26-000065
4 2026-03-03 0001062822-26-000034
4 2026-03-03 0001062822-26-000035
4 2026-03-03 0001062822-26-000036
4 2026-03-03 0001062822-26-000037
4 2026-03-03 0001062822-26-000038
4 2026-03-03 0001062822-26-000039
4 2026-03-03 0001062822-26-000040
4 2026-03-03 0001062822-26-000041

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 15 months Source
Three-year share count growth 81.67% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 35/10) Source
Cash Runway
15 months Source
Share Count Growth (3-Year)
81.67% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.